$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Transdermal formulations, methods and devices 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • A61F-013/02
출원번호 US-0039593 (1993-03-26)
발명자 / 주소
  • Gale Robert M. (Los Altos CA) Nedberge Diane E. (Los Altos CA) Atkinson Linda E. (Portola Valley CA)
출원인 / 주소
  • Alza Corporation (Palo Alto CA 02)
인용정보 피인용 횟수 : 58  인용 특허 : 0

초록

The present invention provides compositions and methods for the transdermal administration of a therapeutically effective amount of a synthetic 19-nor-progesterone (ST-1435) and an estrogen, in combination, together with, optionally, a suitable permeation enhancer.

대표청구항

A composition of matter for the transdermal administration of a drug formulation comprised of an estrogen and ST-1435, the composition comprising, in combination, an amount of the drug formulation to deliver at least 10 m20 m1435 and a skin permeation-enhancing amount of a suitable permeation enhanc

이 특허를 인용한 특허 (58)

  1. Meconi Reinhold,DEX ; Seibertz Frank,DEX, Active substance-containing patch.
  2. Scholz, Matthew T., Cationic antiseptic compositions and methods of use.
  3. Scholz, Matthew T., Cationic antiseptic compositions and methods of use.
  4. Bozik, Michael E.; Petzinger, Jr., Thomas; Mather, James L.; Archibald, Donald, Compositions and methods for treating amyotrophic lateral sclerosis in responders.
  5. Bozik, Michael E.; Petzinger, Jr., Thomas; Mather, James L.; Archibald, Donald, Compositions and methods for treating amyotrophic lateral sclerosis in responders.
  6. Bozik, Michael E.; Dworetzky, Steven, Compositions and methods for treating chronic urticaria.
  7. Bozik, Michael E; Dworetzky, Steven, Compositions and methods for treating chronic urticaria.
  8. Bozik, Michael E.; Hebrank, Gregory; Farwell, Wildon; Petzinger, Jr., Thomas; Dworetzky, Steven, Compositions and methods for treating conditions related to increased eosinophils.
  9. Bozik, Michael E.; Dworetzky, Steven, Compositions and methods for treating plasma cell disorders and B-cell prolymphocytic disorders.
  10. Bozik, Michael E.; Dworetzky, Steven, Compositions and methods for treating plasma cell disorders and B-cell prolymphocytic disorders.
  11. Bozik, Michael E.; Gribkoff, Valentin; Petzinger, Jr., Thomas, Compositions and methods of using (R)-pramipexole.
  12. Bozik, Michael E.; Petzinger, Jr., Thomas; Gribkoff, Valentin, Compositions and methods of using (R)-pramipexole.
  13. Bozik, Michael E.; Petzinger, Jr., Thomas; Gribkoff, Valentin, Compositions of R(+) and S(−) pramipexole and methods of using the same.
  14. Bozik, Michael E.; Petzinger, Jr., Thomas; Gribkoff, Valentin, Compositions of R(+) and S(−) pramipexole and methods of using the same.
  15. Schmirler Dennis Lee ; Portman Edward Malcolm ; Christensen Michael S., Compositions, methods and devices for the transdermal delivery of drugs.
  16. Venkateshwaran Srinivasan ; Fikstad David ; Patel Sonal R., Fatty acid esters of glycolic acid and its salts.
  17. Venkateshwaran Srinivasan ; Fikstad David ; Patel Sonal R., Fatty acid esters of lactic acid salts as permeation enhancers.
  18. Gale, Robert M.; Nelson, Melinda K.; Cormier, Michel J. N.; Gupta, Suneel K.; Campbell, Patricia S., Formulations for the administration of fluoxetine.
  19. Gale,Robert M.; Nelson,Melinda K.; Cormier,Michel J. N.; Gupta,Suneel K.; Campbell,Patricia S., Formulations for the administration of fluoxetine.
  20. van Osdol, William W.; Crisologo, Nieves M.; Yum, Su Il, Formulations for the transdermal administration of fenoldopam.
  21. van Osdol, William W.; Crisologo, Nieves M.; Yum, Su Il, Formulations for the transdermal administration of fenoldopam.
  22. Yum, Su Il; Nelson, Melinda K.; Campbell, Patricia S., Formulations for transdermal delivery of pergolide.
  23. Samour Carlos M. ; Krauser Scott F. ; Gyurik Robert J., Hormone replacement therapy drug formulations for topical application to the skin.
  24. Hildebrand Keith R. ; Fowler Jan Ellen O. ; Levius Dezso K., Incontinence treatment.
  25. Bozik, Michael E.; Petzinger, Jr., Thomas; Gribkoff, Valentin, Modified release formulations of (6R)-4,5,6,7-tetrahydro-N6-propyl-2,6-benzothiazole-diamine and methods of using the same.
  26. Taskovich Lina Tormen (Palo Alto CA) Yum Su Il (Los Altos CA) Crisologo Nieves Marzan (Sunnyvale CA), Monoglyceride/lactate ester permeation enhancer for codelivery of steroids.
  27. Lee Eun Soo ; Watanabe Tyler ; Gale Robert M. ; Burkoth Terry L., Monoglyceride/lactate ester permeation enhancer for oxybutnin.
  28. Lee Eun Soo ; Watanabe Tyler ; Gale Robert M. ; Burkoth Terry L., Monoglyceride/lactate ester permeation enhancer for oxybutynin.
  29. Lee Eun Soo ; Yum Su II, Permeation enhances for transdermal drug delivery compositions, devices and methods.
  30. Scholz, Matthew T., Phenolic antiseptic compositions and methods of use.
  31. Rodriguez,Gustavo C.; Whitaker,Regina Salas, Prevention of ovarian cancer by administration of a Vitamin D compound.
  32. Gustavo C. Rodriguez ; Regina Salas Whitaker, Prevention of ovarian cancer by administration of a vitamin D compound.
  33. Rodriguez, Gustavo C., Prevention of ovarian cancer by administration of products that induce transforming growth factor-β and/or apoptosis in the ovarian epithelium.
  34. Rodriguez, Gustavo C., Prevention of ovarian cancer by administration of products that induce transforming growth factor-beta and/or apoptosis in the ovarian epithelium.
  35. Rodriguez Gustavo C., Prevention of ovarian cancer by administration of progestin products.
  36. Rodriguez, Gustavo C., Prevention of ovarian cancer by administration of progestin products.
  37. Cormier Michel J. N. ; Daddona Peter E. ; Johnson Juanita A., Reduction of skin reactions caused by transdermal drug delivery.
  38. Fein, Seymour, Safe desmopressin administration.
  39. Beste Russell D. ; Hamlin Richard D., Skin permeation enhancer compositions comprising a monoglyceride and ethyl palmitate.
  40. Lee Eun Soo ; Yum Su Il, Skin permeation enhancer compositions using acyl lactylates.
  41. Chiang Chia-Ming ; Tenzel Renee Ann, Solid matrix system for transdermal drug delivery.
  42. Chiang Chia-Ming ; Tenzel Renee Ann, Solid matrix system for transdermal drug delivery.
  43. Chiang Chia-Ming ; Tenzel Renee Ann, Solid matrix system for transdermal drug delivery.
  44. Chen, Weirong; Humora, Michael; Kwok, Daw-Iong Albert; Kiesman, William F.; Irdam, Erwin Ayandra, Synthesis of amine substituted 4,5,6,7-tetrahydrobenzothiazole compounds.
  45. Chen, Weirong; Humora, Michael; Kwok, Daw-long Albert; Kiesman, William F.; Irdam, Erwin Ayandra, Synthesis of amine substituted 4,5,6,7-tetrahydrobenzothiazole compounds.
  46. Raje, Prasad; Gadikota, Rajendrakumar Reddy; Chen, Jian-Xie; Lapina, Olga V.; McCall, John M., Synthesis of chirally purified substituted benzothiazole diamines.
  47. Raje, Prasad; Gadikota, Rajendrakumar Reddy; Chen, Jian-Xie; Lapina, Olga V.; McCall, John M., Synthesis of chirally purified substituted benzothiazole diamines.
  48. Chien Yie W. ; Chien Te-Yen ; Gong Sai-Jun, Transdermal contraceptive delivery system and process.
  49. Jona Janan ; Audett Jay ; Singh Noel, Transdermal patch and method for administering 17-deacetyl norgestimate alone or in combination with an estrogen.
  50. Jona Janan ; Audett Jay ; Singh Noel, Transdermal patch and method for administering 17-deacetyl norgestimate alone or in combination with an estrogen.
  51. Jona Janan ; Audett Jay ; Singh Noel, Transdermal patch and method for administering 17-deacetyl norgestimate alone or in combination with an estrogen.
  52. Gale, Robert M., Transparent transdermal nicotine delivery devices.
  53. Gale, Robert M., Transparent transdermal nicotine delivery devices.
  54. Gale, Robert M., Transparent transdermal nicotine delivery devices.
  55. Gale, Robert M., Transparent transdermal nicotine delivery devices.
  56. Gale, Robert M., Transparent transdermal nicotine delivery devices.
  57. Bond, Richard A.; Glass, Mitchell, Use of beta-adrenergic inverse agonists for smoking cessation.
  58. Elger,Walter; L채hteenm채ki,Pekka; Lehtinen,Matti; Reddersen,Gudrun; Zimmermann,Holger; Oettel,Michael; Schwarz,Sigfrid, Use of biogenic estrogen sulfamates for hormone replacement therapy.
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로